iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
Provided By GlobeNewswire
Last update: Oct 23, 2025
SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), an AI-driven innovator of precision antibody therapies, today announced that it will participate in the Guggenheim 2nd Annual Healthcare Innovation Conference, taking place November 10–12, 2025 in Boston.
Read more at globenewswire.com1.76
+0.16 (+10%)
Find more stocks in the Stock Screener
IBIO Latest News and Analysis
